牛牛AI助理已提取核心訊息
Bristol-Myers Squibb (BMS) has announced the offering of multiple series of notes under its senior unsecured debt category. The notes, with varying interest rates and maturity dates, are to be issued under an indenture dated June 1, 1993. The offering includes 8 different series of notes, each with its own fixed interest rate and maturity date ranging from 2024 onwards. The notes will be offered to the public through underwriters and the proceeds are intended for general corporate purposes, which may include debt repayment, investments, share repurchases, or acquisitions. The completion of the offering is subject to market conditions and customary closing terms. The announcement details the involvement of joint lead managers and joint book-running managers, including Citigroup, BofA Securities, Wells Fargo Securities, and Mizuho. The specific terms of the notes, including interest rates and maturity dates, will be determined at the time of sale and disclosed in a prospectus supplement. BMS has filed the necessary documentation with the SEC and the notes will be available for purchase through the underwriters.
Bristol-Myers Squibb (BMS) has announced the offering of multiple series of notes under its senior unsecured debt category. The notes, with varying interest rates and maturity dates, are to be issued under an indenture dated June 1, 1993. The offering includes 8 different series of notes, each with its own fixed interest rate and maturity date ranging from 2024 onwards. The notes will be offered to the public through underwriters and the proceeds are intended for general corporate purposes, which may include debt repayment, investments, share repurchases, or acquisitions. The completion of the offering is subject to market conditions and customary closing terms. The announcement details the involvement of joint lead managers and joint book-running managers, including Citigroup, BofA Securities, Wells Fargo Securities, and Mizuho. The specific terms of the notes, including interest rates and maturity dates, will be determined at the time of sale and disclosed in a prospectus supplement. BMS has filed the necessary documentation with the SEC and the notes will be available for purchase through the underwriters.
百時美施貴寶（BMS）宣佈在其優先無抵押債務類別下發行多個系列票據。這些票據的利率和到期日各不相同，將根據1993年6月1日的契約發行。本次發行包括8種不同系列的票據，每種票據都有自己的固定利率，到期日從2024年起。這些票據將通過承銷商向公衆發行，所得款項將用於一般公司用途，其中可能包括債務償還、投資、股票回購或收購。本次發行的完成取決於市場狀況和慣例成交條款。該公告詳細介紹了包括花旗集團、美銀證券、富國銀行證券和瑞穗在內的聯席牽頭經紀人和聯席賬簿管理人的參與。票據的具體條款，包括利率和到期日，將在出售時確定，並在招股說明書補充文件中披露。BMS已向美國證券交易委員會提交了必要的文件，這些票據將可通過承銷商購買。
百時美施貴寶（BMS）宣佈在其優先無抵押債務類別下發行多個系列票據。這些票據的利率和到期日各不相同，將根據1993年6月1日的契約發行。本次發行包括8種不同系列的票據，每種票據都有自己的固定利率，到期日從2024年起。這些票據將通過承銷商向公衆發行，所得款項將用於一般公司用途，其中可能包括債務償還、投資、股票回購或收購。本次發行的完成取決於市場狀況和慣例成交條款。該公告詳細介紹了包括花旗集團、美銀證券、富國銀行證券和瑞穗在內的聯席牽頭經紀人和聯席賬簿管理人的參與。票據的具體條款，包括利率和到期日，將在出售時確定，並在招股說明書補充文件中披露。BMS已向美國證券交易委員會提交了必要的文件，這些票據將可通過承銷商購買。
有用
沒用